In vivo adeno-associated virus-mediated LDLR/PCSK9 intervention for familial hypercholesterolemia

In vivo adeno-associated virus-mediated LDLR/PCSK9 intervention for familial hypercholesterolemia

Saved in:

Bibliographic Details
Main Authors:	Zeyu Han, Cheng Tan, Jianzhong Ai, Ye Zhu
Format:	Article
Language:	English
Published:	KeAi Communications Co., Ltd. 2025-11-01
Series:	Genes and Diseases
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352304225001217
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

PCSK9-promoted LDLR degradation: Recruitment or prevention of essential cofactors?
by: Rong Li, et al.
Published: (2025-06-01)

Sex and racial differences in prevalence and clinical characteristics of people living with LDLR and PCSK9 familial hypercholesterolemia genetic variants: Data from the All of Us Research program
by: Jeffery Osei, et al.
Published: (2025-06-01)

CO18 | Relationship between gut permeability and PCSK9 in heterozygous familial hypercholesterolemia
Published: (2025-08-01)

Phenotypical features of heterozygous familial hypercholesterolemia in individuals with LDLR or APOB gene mutations
by: A. N. Meshkov, et al.
Published: (1970-01-01)

Family hypercholesterolemia due to LDLR gene in Vietnamese children: characteristics of phenotype and genotype
by: Mai Thi Thanh Do, et al.
Published: (2025-06-01)

Testosterone Deficiency Promotes Hypercholesteremia and Attenuates Cholesterol Liver Uptake via AR/PCSK9/LDLR Pathways
by: Yu Yuefeng, et al.
Published: (2022-01-01)

The Use of PCSK9 Inhibitor Is Associated With More Adaptative Eating Behaviors Among Adults With Heterozygous Familial Hypercholesterolemia
by: Clémence Desjardins, et al.
Published: (2025-05-01)

Targeted disruption of LDLR causes hypercholesterolemia and atherosclerosis in Yucatan miniature pigs.
by: Bryan T Davis, et al.
Published: (2014-01-01)

Exploring LDLR-APOB Interactions in Familial Hypercholesterolemia in the Vietnamese Population: A Protein-Protein Docking Approach
by: Ngoc-Thanh Kim, et al.
Published: (2024-11-01)

Kratom leaf extracts exert hypolipidaemic effects via the modulation of PCSK9 and LDLR pathways in HepG2 cells
by: Nantiya Nawaka, et al.
Published: (2025-05-01)

Genetic screening of malay familial hypercholesterolemia patient for LDLRAP1/PCSK9/APOB mutations via whole exome sequencing
by: Muhammad-Redha Abdullah-Zawawi, et al.
Published: (2025-03-01)

ASSOTIATION OF THE GENETIC POLYMORPHISM E670G OF THE PCSK-9 AND THE SEVERITY OF THE CAROTID ATHEROSCLEROSIS IN PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA IN UZBEK POPULATION
by: R. B. Alieva, et al.
Published: (2019-09-01)

Correction: Genetic associations between serum low LDL-cholesterol levels and variants in LDLR, APOB, PCSK9 and LDLRAP1 in African populations.
by: Mahtaab Hayat, et al.
Published: (2021-01-01)

Phenotype of heterozygous familial hypercholesterolemia caused by deletion of <i>LDLR</i> gene exons 2-10: a case report
by: A. M. Moiseeva, et al.
Published: (2024-12-01)

Prevalence and penetrance of pathogenic and likely pathogenic LDLR and APOB gene variants linked to familial hypercholesterolemia and increased risk of ischemic heart disease
by: I. K. Dzhumaniiazova, et al.
Published: (2025-08-01)

ANGPTL3, ANGPTL4, APOA5, APOB, APOC2, APOC3, LDLR, PCSK9, LPL gene variants and coronary artery disease risk
by: A. N. Meshkov, et al.
Published: (2022-11-01)

New epigenome players in the regulation of PCSK9-H3K4me3 and H3K9ac alterations by statin in hypercholesterolemia
by: Sushmitha Duddu, et al.
Published: (2025-01-01)

PCSK9-antibodies fail to block PCSK9-induced inflammation in macrophages and cannot recapitulate protective effects of PCSK9-deficiency in experimental myocardial infarction
by: Simon Rauterberg, et al.
Published: (2025-01-01)

Familial hypercholesterolemia
by: Pankaj Singhania, et al.
Published: (2022-05-01)

PCSK9 Inhibitors: The Evolving Future
by: Bijay Mukesh Jeswani, et al.
Published: (2024-11-01)

PCSK9 in T-cell function and the immune response
by: Yuying Wang, et al.
Published: (2024-12-01)

Protocol for adeno-associated virus-mediated gene delivery to accelerate pancreatic carcinogenesis in mice
by: Hongzhen Li, et al.
Published: (2025-09-01)

PCSK9 Modulates Macrophage Polarization-Mediated Ventricular Remodeling after Myocardial Infarction
by: Feifei Wang, et al.
Published: (2022-01-01)

Cell tropism of adeno-associated viruses within the mouse inner ear in vivo: from embryonic to adult stages
by: Sepideh Iranfar, et al.
Published: (2025-04-01)

Adeno-Associated Virus Vectors for Therapeutic Gene Transfer
by: Jackie L. Stilwell, et al.
Published: (2003-01-01)

Adeno-associated virus-clustered regularly interspaced short palindromic repeats/cas9‑mediated ovarian cancer treatment targeting PD-L1
by: Tamaki Yahata, et al.
Published: (2025-04-01)

Analysis of The Use of PCSK9 Inhibitors in Clinical Practice
by: S. Yu. Volkova, et al.
Published: (2023-03-01)

Current Evidence and Future Directions of PCSK9 Inhibition
by: Jiaqian Xu, et al.
Published: (2021-02-01)

RHEUMATIC MANIFESTATIONS OF FAMILIAL HYPERCHOLESTEROLEMIA
by: Lyudmila Valeryevna Teplova, et al.
Published: (2012-10-01)

Dietary Approach in Familial Hypercholesterolemia
by: Joanna Popiolek-Kalisz, et al.
Published: (2025-01-01)

Carotenoid Interactions with PCSK9: Exploring Novel Cholesterol-Lowering Strategies
by: Alessandro Medoro, et al.
Published: (2024-11-01)

Adeno‐Associated Virus 8 and 9 Myofibre Type/Size Tropism Profiling Reveals Therapeutic Effect of Microdystrophin in Canines
by: Matthew J. Burke, et al.
Published: (2025-02-01)

Short-term effects of PCSK-9 inhibitors on percutaneous coronary intervention in patients with acute coronary syndrome
by: Dong Hyun Gim, et al.
Published: (2025-05-01)

Adeno-associated virus mediated artificial circular RNA for triggering cancer immunotherapy to treat prostate cancer
by: Chujin Ye, et al.
Published: (2025-01-01)

A dual-reporter LDLR system integrating fluorescence and luminescence for understanding LDLR regulation and facilitating drug discovery
by: Peng Jiao, et al.
Published: (2025-03-01)

A dietary combination of red yeast rice, phytosterol ester and lycopene ameliorates hypercholesterolemia by regulating gut microbiota and activating hepatic FXR-LDLR/ABCG pathway in mice
by: Jingxian Xu, et al.
Published: (2025-08-01)

Mechanisms of action and therapeutic potential of PCSK9-regulating drugs
by: Chenrui Qi, et al.
Published: (2025-12-01)

Early effects of PCSK9 inhibitors: evolocumab versus alirocumab
by: Su-Hyun Bae, et al.
Published: (2025-03-01)

Engineering chimeric PCSK9 for a vaccine against atherosclerosis
by: Špela Malenšek, et al.
Published: (2025-09-01)

Prospects of Using PCSK9 Inhibitors for Acute Coronary Syndrome
by: A. M. Namitokov, et al.
Published: (2024-04-01)